Navigation Links
Geriatrician from Regenstrief Institute and Indiana University honored
Date:2/14/2012

INDIANAPOLIS -- In recognition of his significant contributions to the health care of older adults, Regenstrief Institute investigator Malaz Boustani, M.D., MPH, associate professor of medicine at the Indiana University School of Medicine, will receive the 2012 American Geriatrics Society Outstanding Scientific Achievement for Clinical Investigation Award. The honor will be presented at the American Geriatrics Society annual meeting in Seattle in May.

Dr. Boustani is a geriatrician. He is associate director of the IU Center for Aging Research and medical director of the Healthy Aging Brain Center at Wishard Health Services. He leads the Indianapolis Discovery Network for Dementia and is the president-elect of the American Delirium Society.

He heads a National Institute on Aging-funded study investigating the effectiveness of drug management of delirium in intensive care units. According to the American Delirium Society more than 7 million hospitalized Americans suffer from delirium each year, although six out of 10 cases are not recognized.

Dr. Boustani is also conducting a comparative effectiveness clinical trial of anti-dementia drugs funded by the U.S. Agency for Healthcare Research and Quality. The Alzheimer Society (UK) estimates 24 million people worldwide have some form of dementia.

The Outstanding Scientific Achievement for Clinical Investigation Award was established to recognize outstanding achievement in clinical research addressing health care problems of older adults by an investigator who is actively involved in direct patient care.

Dr. Boustani is being recognized for his dedication to improving the care of older adults with dementia and delirium, his work on the development of clinical assessment tools and treatment approaches, and his research contributions in improving the performance of health care providers and health care systems.

"Malaz Boustani is a strong, vocal and visible advocate for older adults and aging research," said Regenstrief Institute investigator Christopher M. Callahan, M.D., Cornelius and Yvonne Pettinga Professor at the IU School of Medicine and director of the IU Center for Aging Research. "His studies have included patient surveys, development of new clinical assessment tools, testing of new treatment approaches and testing of new models of care. He has led the conception, design, funding and staffing of the Healthy Aging Brain Center, now in its third year of operation. He has made exceptional contributions to clinical research addressing health care problems of older adults."

Dr. Boustani received an M.D. degree from Damascus University in Damascus, Syria, and an MPH degree from the University of North Carolina, where he also completed a fellowship in geriatric medicine. He is the author of more than 75 peer-reviewed publications.


'/>"/>
Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. UofL geriatrician selected for new federal Innovation Advisors Program
2. Geriatrician advocates for improvements to primary care to meet the needs of older adults
3. Regenstrief investigator a winner of Top 11 in 2011 Innovator Challenge
4. Regenstrief Institute president to receive national recognition
5. AMIA honors Regenstrief Institutes President and CEO with 2011 Morris F. Collen Award
6. Innovation at Regenstrief: Leveraging novel ideas to improve health care
7. IU-Regenstrief programs targeted to alleviate shortage of health IT workforce
8. IU and Regenstrief address critical need for health IT professionals
9. Regenstrief releasing new version of lingua franca needed for electronic health info exchange
10. Measuring success: Regenstrief helps assess value of investment in health info tech
11. RXplore: New Regenstrief tool lets docs instantly track down drug reactions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Geriatrician from Regenstrief Institute and Indiana University honored
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: